Biodexa Pharmaceuticals American Depositary Shs Stock Forecast

Sell candidate since Jun 10, 2026 Loss -2.99%

The Biodexa Pharmaceuticals Plc American stock price gained 16.80% on the last trading day (Friday, 26th Jun 2026), rising from $2.50 to $2.92. During the last trading day the stock fluctuated 22.31% from a day low at $2.51 to a day high of $3.07. The price has fallen in 6 of the last 10 days and is down by -5.26% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 4 million more shares were traded than the day before. In total, 4 million shares were bought and sold for approximately $11.84 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.67% during the next 3 months and, with a 90% probability hold a price between $2.20 and $4.00 at the end of this 3-month period.

BDRX Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, June 25, 2026, and so far it has risen 16.80%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Biodexa Pharmaceuticals Plc American stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $3.28. On a fall, the stock will find some support from the short-term average at $2.82. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Biodexa Pharmaceuticals Plc American stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.66 and $2.61. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Biodexa Pharmaceuticals Plc American finds support just below today's level at $2.66. If this is broken, then the next support from accumulated volume will be at $2.61 and $2.50.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.560 between high and low, or 22.31%. For the last week, the stock has had daily average volatility of 11.79%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BDRX) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Biodexa Pharmaceuticals Plc American Depositary Shs to open at $2.83, and during the day (based on 14 day Average True Range), to move between $2.79 and $3.05, which gives a possible trading interval of +/-$0.265 (+/-9.52%) up or down from last closing price. If Biodexa Pharmaceuticals Plc American Depositary Shs takes out the full calculated possible swing range there will be an estimated 9.52% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.66 (8.90%) than the resistance at $3.25 (11.30%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Biodexa Pharmaceuticals Plc American Depositary Shs stock A Buy?

Biodexa Pharmaceuticals Plc American holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -1.498 Sell Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 29, 2026 - $2.83 ( 2.97%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk